找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Artificial Oxygen Carrier; Its Frontline Koichi Kobayashi (Chief Professor of Surgery),Eish Conference proceedings 2005 Springer-Verlag Tok

[復制鏈接]
樓主: 聲音會爆炸
41#
發(fā)表于 2025-3-28 17:09:04 | 只看該作者
42#
發(fā)表于 2025-3-28 20:41:08 | 只看該作者
Isolation and Culture of Skin Fibroblastsing a hemoglobin (Hb)-based oxygen carrier. In this chapter, we have summarized the characteristics and performances of Hb-vesicles (HbV) that have been developed on the basis of molecular assembly. Collaborative in vitro and in vivo studies have revealed sufficient safety and efficacy of HbV.
43#
發(fā)表于 2025-3-28 23:46:29 | 只看該作者
44#
發(fā)表于 2025-3-29 04:19:03 | 只看該作者
45#
發(fā)表于 2025-3-29 07:23:06 | 只看該作者
978-4-431-54636-8Springer-Verlag Tokyo 2005
46#
發(fā)表于 2025-3-29 12:24:26 | 只看該作者
Safety and Efficacy of Hemoglobin-Vesicles and Albumin-Hemes,s have been selected from the viewpoints of safety, efficacy, and cost performance. One is Hemoglobin-vesicles (HbV) and the other is albumin-heme (rHSA-heme). This chapter summarizes our video presentation that introduced the recent results of our research into HbV and rHSA-heme.
47#
發(fā)表于 2025-3-29 18:35:43 | 只看該作者
Hemoglobin-Vesicles (HbV) as Artificial Oxygen Carriers,ing a hemoglobin (Hb)-based oxygen carrier. In this chapter, we have summarized the characteristics and performances of Hb-vesicles (HbV) that have been developed on the basis of molecular assembly. Collaborative in vitro and in vivo studies have revealed sufficient safety and efficacy of HbV.
48#
發(fā)表于 2025-3-29 22:17:19 | 只看該作者
Intravascular Microbubbles: An Ultra-Effective Means of Transporting Oxygen,able to transport physiologically significant amounts of oxygen in animal experiments. Thus, the treatment sustained life in rats and pigs with potentially fatal erythrocytopenia caused by hemorrhage and hemodilution, and adequate oxygenation was preserved in severe right-to-left circulatory shunts caused by partial airway blockage in pigs.
49#
發(fā)表于 2025-3-29 23:57:52 | 只看該作者
50#
發(fā)表于 2025-3-30 06:44:50 | 只看該作者
 關于派博傳思  派博傳思旗下網站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網 吾愛論文網 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經驗總結 SCIENCEGARD IMPACTFACTOR 派博系數 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網安備110108008328) GMT+8, 2025-10-24 07:07
Copyright © 2001-2015 派博傳思   京公網安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
松桃| 长寿区| 榕江县| 丰台区| 富锦市| 东宁县| 中卫市| 兴化市| 乌兰察布市| 西藏| 蓬安县| 囊谦县| 长岛县| 肇源县| 陇川县| 霸州市| 老河口市| 金门县| 大埔区| 马鞍山市| 绥阳县| 深泽县| 玉山县| 瑞丽市| 那曲县| 乾安县| 温州市| 贵阳市| 陆良县| 古交市| 五原县| 磐安县| 赤壁市| 泸定县| 舟山市| 庆城县| 莒南县| 太和县| 兴安盟| 广西| 香港|